Skip to main content
Contact Us
Subscribe
E-Edition
79°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Teva Pharmaceutical Industries ADR
(NY:
TEVA
)
16.79
-0.12 (-0.71%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Teva Pharmaceutical Industries ADR
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Israel-Hamas War News: Top 15 Israeli-Based US-Traded Stocks Continue To Slide
November 12, 2023
The Israel-Hamas War is adversely affecting everything in Israel, including the stock performances of the 15 Israeli companies with market capitalizations of $2B or more that are listed on the Nasdaq...
Via
Talk Markets
Teva Pharmaceutical Industries (TEVA) Q3 2023 Earnings Call Transcript
November 08, 2023
TEVA earnings call for the period ending September 30, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Teva Pharmaceutical Lifts Revenue Forecast - Huntington's And Migraine Drugs Help Q3 Performance
November 08, 2023
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) reported Q3 sales of $3.85 billion, beating the consensus of $3.72 billion
Via
Benzinga
Teva Closes In On A Buy Point On Third-Quarter Beat, Business Separation
November 08, 2023
The company named a new chief executive for its Teva api business.
Via
Investor's Business Daily
US Stocks Set To Open Flat After Hot 7-Day Rally: Traders Sharpen Focus On Powell's Speech, Disney Earnings
November 08, 2023
Stock futures indicate a subdued opening on Wednesday after several consecutive gains in major averages. Traders are eagerly awaiting Federal Reserve Chair Jerome Powell’s speech for insights into...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Earnings Scheduled For November 8, 2023
November 08, 2023
Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter.
Via
Benzinga
Alkermes Q3 Earnings Top Consensus, On Track To Separate Oncology Business, Reaffirms FY23 Outlook
October 25, 2023
Alkermes PLC (NASDAQ: ALKS) reported Q3 FY23 adjusted EPS of $0.64 compared to $0.02 a year ago, beating the
Via
Benzinga
Roche Spends $7.1 Billion On Roivant Drug, Following Merck, Sanofi Into The Raging Hot Immunology Space
October 23, 2023
Roche is joining Merck and Sanofi in the TL1A drug space. These drugs could treat stomach diseases.
Via
Investor's Business Daily
Israeli-Hamas War: U.S. Exchange-Listed Israeli Stocks Continue To Decline
October 22, 2023
The 111 Israeli companies with stocks trading on US exchanges have combined market caps over $150B. Or at least they did midweek: since the Hamas-Israeli War began October 7th, pretty much everything...
Via
Talk Markets
Investor Exit Israel ETFs Following Attacks, But Remain Confident In Large-Caps
October 19, 2023
Israel-focused ETFs have plunged since the last trading day before Hamas launched surprise attacks on Israel, while some Israeli companies listed in the U.S. have so far escaped repercussions to their...
Via
Benzinga
Topics
ETFs
Thoughts For Thursday: War Worries Rattle The Market
October 19, 2023
Via
Talk Markets
Hamas-Israeli War: US Exchange Listed Israeli Stocks Hit Hard
October 18, 2023
111 Israeli companies trade on U.S. stock exchanges of which only 15 have market capitalization of $2B or more.
Via
Talk Markets
Israel Could Form Emergency Government: Defense Stocks, Israel ETFs In Focus During Conflict
October 10, 2023
As Israel ramps up its armed forces and a regional war with Hamas enters its fourth day, the country is considering forming an emergency government.
Via
Benzinga
Topics
ETFs
Israeli Stocks Fall as Investors Fear Middle East Conflict
October 09, 2023
The recent attacks on Israel will have a lasting economic impact. Here's what investors should know about Israeli stocks.
Via
InvestorPlace
Cathie Wood's ARK Israel Innovative Tech ETF Braces For Impact Amid Regional Warfare: 10 Stocks To Watch
October 09, 2023
Discover how Cathie Wood's ARK Israel Innovative Tech ETF responds to the Israel-Hamas conflict. Explore its portfolio performance and top Israeli stocks to watch amidst geopolitical turmoil.
Via
Benzinga
Topics
ETFs
Why Teva Pharmaceutical (TEVA) Stock Is Falling
October 09, 2023
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) shares are trading lower by 2.7% to $9.17 Monday morning amid conflict in the company's home country, Israel.
Via
Benzinga
Middle East War Hammers Israel-Based Stocks But Lifts Defense, Oil Names
October 09, 2023
Israel stocks, regardless of industry, sank Monday following the terrorist attack on Israel.
Via
Investor's Business Daily
Palantir And PwC Team Up To Accelerate Data-Driven Operations, OpenAI Rival Secures Billions In Big Tech Backing, Six US States Brace For Healthcare Strike: Today's Top Stories
October 04, 2023
Benzinga
Via
Benzinga
Teva Pharma Hooks Sanofi In $1.5 Billion Inflammation Deal. But Shares Tumble.
October 04, 2023
The deal leans into the emerging TL1A drug class, potentially rivaling Roivant and Merck.
Via
Investor's Business Daily
Sanofi, Teva Pledge $1.5B To Target Inflammatory Bowel Disease That Impacts Almost 10M People
October 04, 2023
Sanofi SA (NASDAQ: SNY) and Teva Pharmaceutical Industries Ltd (NYSE: TEVA) have collaborated to co-develop and
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
October 02, 2023
Via
Benzinga
Apple Defends Its $19B Google Search Deal, Hollywood's Writers Secure Credit For AI Training, China's Ambitious Chip Fund Faces Headwinds: Today's Top Stories
September 27, 2023
Benzinga Alibaba's Logistics Arm Cainiao Files For Hong Kong IPO
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Migraine Medication Battle: Eli Lilly Prevails in Patent Infringement Case Against Teva
September 27, 2023
A federal judge in Massachusetts has overturned a $176.5 million jury verdict against Eli Lilly And Co (NYSE: LLY). T
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Despite Efforts, Vulnerable Patients Still Face Barriers to Essential Medicines, Says New Report
September 26, 2023
Despite significant initiatives by generic drug companies to broaden access to vital medicines, many vulnerable patients remain underserved, according to findings from a new study from the Access to...
Via
Benzinga
3 No-Brainer Stocks to Buy With $20 Right Now
September 13, 2023
You don't need a boatload of cash to begin growing your wealth on Wall Street.
Via
The Motley Fool
Why Can't You Find Adderall? Inside the Ongoing Shortage of ADHD Medication In US
September 12, 2023
Last year, Teva Pharmaceutical Industries Ltd (NYSE: TEVA), the primary producer of Adderall, faced shortages
Via
Benzinga
TEVA - A Pharma Stock To Watch
September 11, 2023
TEVA is one of the few instruments that has handily cleared its July 6-month calendar range high. The 50 daily moving average is about to cross or golden cross the 200-DMA and enter a bullish phase.
Via
Talk Markets
10 Health Care Stocks With Whale Alerts In Today's Session
September 11, 2023
Via
Benzinga
How A Small Indian Firm Firm Was Pulled Into A Legal Battle with Big Pharma Over A Cancer Drug
September 11, 2023
This story was first published on the Benzinga India portal.
Via
Benzinga
Bristol Myers' Antitrust Allegations: Lawsuit Over Alleged Patent Deception For Blood Cancer Drug
September 07, 2023
Bristol Myers Squibb Co (NYSE: BMY) faces fresh allegations in a recent lawsuit, accused of employing deceptive patents and illicit strategies to preserve its dominant position in the blood cancer drug...
Via
Benzinga
Topics
Intellectual Property
Lawsuit
Exposures
Financial
Intellectual Property
Legal
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.